• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Fractyl Health, Inc. - Common Stock (NQ: GUTS )

    3.380 -0.110 (-3.15%)
    Streaming Delayed Price Updated: 12:12 PM EDT, Aug 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 173,508
    Open 3.480
    Bid (Size) 3.370 (2)
    Ask (Size) 3.390 (7)
    Prev. Close 3.490
    Today's Range 3.330 - 3.500
    52wk Range 1.740 - 14.50
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    GUTS Stock Earnings: Fractyl Health Beats EPS for Q2 2024
    GUTS stock results show that Fractyl Health beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
    From Fractyl Health, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -73.70%
    -73.70%
    1 Month
    -17.36%
    -17.36%
    3 Month
    -48.55%
    -48.55%
    6 Month
    -62.94%
    -62.94%
    1 Year
    -73.70%
    -73.70%

    More News

    Read More
    Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
    From Fractyl Health, Inc.
    Via GlobeNewswire
    Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
    From Fractyl Health, Inc.
    Via GlobeNewswire
    Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
    From Fractyl Health, Inc.
    Via GlobeNewswire
    Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
    From Fractyl Health, Inc.
    Via GlobeNewswire
    Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
    From Fractyl Health, Inc.
    Via GlobeNewswire
    Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s
    From Fractyl Health, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
    From Fractyl Health, Inc.
    Via GlobeNewswire
    Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
    From Fractyl Health, Inc.
    Via GlobeNewswire
    GUTS Stock Earnings: Fractyl Health Beats EPS for Q1 2024
    Via InvestorPlace
    Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
    From Fractyl Health, Inc.
    Via GlobeNewswire
    Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
    From Fractyl Health, Inc.
    Via GlobeNewswire
    Fractyl Health to Present at BofA Securities 2024 Health Care Conference
    From Fractyl Health, Inc.
    Via GlobeNewswire
    Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
    From Fractyl Health, Inc.
    Via GlobeNewswire
    Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
    From Fractyl Health, Inc.
    Via GlobeNewswire
    The 3 Most Volatile Stocks for Short-Term Traders: April 2024
    Via InvestorPlace
    Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
    From Fractyl Health, Inc.
    Via GlobeNewswire
    Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    PVH Posts Q4 Results, Joins Humana, CVS Health And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.